OSAM
AMPE

O'Shaughnessy Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 2907
2021
Q2 		$0 Hold
1
– – ﹤0.01% 2737
2021
Q1 		$1K Sell
1
-1
-50% -$516 ﹤0.01% 2333
2020
Q4 		$1K Buy
+2
New +$656 ﹤0.01% 2035

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

O'Shaughnessy Asset Management's AMPE Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2021, closing a stake of 1 share.

O'Shaughnessy Asset Management first reported a position in AMPE in Q4 2020 and held it in 3 quarters. The position peaked at $1K in Q1 2021. 121 funds tracked by Wall St. Rank hold AMPE as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1 Ampio Pharmaceuticals Inc. share in Q3 2021.
  • O'Shaughnessy Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 3 quarters.
  • O'Shaughnessy Asset Management's Ampio Pharmaceuticals Inc. position peaked at $1K in Q1 2021.
  • 121 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.